Clinical Trials

Phase 2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck

NCT03930498 2025-01-28

Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma

68 enrolled

Nasopharyngeal Carcinoma

NCT04857164 2025-01-28

Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in China

150 enrolled

Phase 2 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT06714266 2024-12-03

Trilaciclib in Preventing Hematopoietic Suppression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

30 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04731740 2024-03-25

Pembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid Cancer

Phase 2 Withdrawn

Thyroid Neoplasms

NCT05011227 2024-03-06

Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma

100 enrolled

Nasopharyngeal Carcinoma

NCT06170697 2023-12-20

Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma

46 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT06130332 2023-11-14

Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004)

40 enrolled

Mouth Neoplasms

NCT02126969 2023-03-13

A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN

45 enrolled 13 charts

Head and Neck Neoplasms, Laryngeal Diseases, Neoplasms

NCT04813705 2023-02-21

18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma

93 enrolled

Nasopharyngeal Carcinoma

NCT05549466 2023-02-08

Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC

84 enrolled

Nasopharyngeal Carcinoma

NCT03982537 2022-12-19

Effect of N-Acetyl Cysteine (NAC) on the Oral Microbiome

Phase 2 Withdrawn

Head and Neck Neoplasms

NCT04398056 2022-07-06

Chemotherapy Plus Subsequent Loco-regional Radiotherapy Combined With Toripalimab in the De Novo Metastatic Nasopharyngeal Carcinoma

22 enrolled

Nasopharyngeal Carcinoma

NCT05350891 2022-05-10

Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC

77 enrolled

Nasopharyngeal Carcinoma

NCT03067610 2022-03-17

INFIELD

72 enrolled 14 charts

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Pharyngeal Neoplasms

NCT05136768 2021-11-29

LM-HNSCC

50 enrolled

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis

NCT02052960 2021-11-02

RESGEX

240 enrolled 16 charts

Squamous Cell Carcinoma of Head and Neck

NCT03101514 2021-06-23

Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study

53 enrolled 11 charts

Head & NeckOther

Head and Neck Neoplasms, Neoplasms, Mucositis

NCT04826679 2021-04-01

Neoadjuvant Camrelizumab in Combination With Cisplatin and Nab-paclitaxel in Resectable HNSCC

53 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03989830 2020-10-23

SLICER

53 enrolled

Head and Neck Neoplasms

NCT04220749 2020-09-04

Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma

68 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00833261 2020-08-21

Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer

37 enrolled 6 charts

Phase 2 Not yet recruiting

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Tongue Neoplasms, Carcinoma, Verrucous

NCT04447326 2020-06-25

Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma

106 enrolled

Nasopharyngeal Carcinoma

NCT04319471 2020-03-24

Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

70 enrolled

Nasopharyngeal Carcinoma

NCT03923842 2020-02-17

Dern

45 enrolled

Nasopharyngeal Carcinoma

NCT03020329 2019-08-07

Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

37 enrolled

Nasopharyngeal Carcinoma

NCT03890185 2019-03-26

Docetaxal & Cisplatin vs LDFRT + Docetaxal & Cisplatin in Locally Advanced NPC

108 enrolled

Nasopharyngeal Neoplasms

NCT01525927 2017-12-19

Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity

Phase 2 Terminated

2 enrolled

Oropharyngeal Neoplasms

NCT00547157 2017-03-15

Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck

152 enrolled 18 charts

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms

NCT02549742 2017-01-18

Electrochemotherapy on Head and Neck Cancer

25 enrolled

Head and Neck Neoplasms

NCT01425736 2014-06-03

Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma

91 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT00095641 2013-11-08

S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer

Phase 2 Withdrawn